Early Implementation and Outcomes Among People with HIV Who Accessed Long-Acting Injectable Cabotegravir/Rilpivirine at Two Ryan White Clinics in the U.S. South.

导出 OA

翻译打印收藏纠错

第一作者： Grace C,Haser

第一单位： Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.

作者： Grace C,Haser ^[1] ; Laurence,Balter ^[2] ; Stephen,Gurley ^[1] ; Marsha,Thomas ^[3] ; Thomas,Murphy ^[3] ; Jeri,Sumitani ^[4] ; Eric Paul,Leue ^[4] ; Angela,Hollman ^[3] ; Maima,Karneh ^[3] ; Leah,Wray ^[3] ; Melissa,Washington ^[4] ; Della,Corbin-Johnson ^[4] ; Alton,Condra ^[4] ; Larisa,Niles-Carnes ^[4] ; Bradley L,Smith ^[4] ; Wendy S,Armstrong ^[5] ; Ameeta S,Kalokhe ^[2] ; Jonathan A,Colasanti ^[5] ; Lauren F,Collins ^[5]

作者单位： Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA. ^[1] Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.;Infectious Diseases Clinic, Emory University Hospital Midtown, Atlanta, Georgia, USA. ^[2] Infectious Diseases Clinic, Emory University Hospital Midtown, Atlanta, Georgia, USA. ^[3] Ponce de Leon Center, Grady Health System, Atlanta, Georgia, USA. ^[4] Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.;Ponce de Leon Center, Grady Health System, Atlanta, Georgia, USA. ^[5]

关键词 Southern HIV/AIDS epidemic antiretroviral switch therapy cabotegravir/rilpivirine-intramuscular implementation science long-acting injectable antiretroviral therapy